Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Solid Tumors × selinexor × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Leukemia, Myeloid, Acute 11 Multiple Myeloma 6 Sarcoma 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Large B-Cell, Diffuse 3 Recurrence 2 Neurofibrosarcoma 2 Neoplasm Metastasis 2 Myelodysplastic Syndromes 2 Melanoma 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Biphenotypic, Acute 2 Glioblastoma 2 Congenital Abnormalities 2 Colorectal Neoplasms 2 Central Nervous System Neoplasms 2 Adenocarcinoma 2 Waldenstrom Macroglobulinemia 1 Stomach Neoplasms 1 Solid Tumors 1 Sarcoma, Ewing 1 Sarcoma, Endometrial Stromal 1 Sarcoma, Alveolar Soft Part 1 Rhabdoid Tumor 1 Rectal Neoplasms 1 Ovarian Neoplasms 1

Interventions

Paclitaxel 11 Gemcitabine 9 Carboplatin 8 atezolizumab 6 Bevacizumab 6 navitoclax 4 liposomal doxorubicin 4 Irinotecan 4 Erlotinib Hydrochloride 4 Cetuximab 4 Sunitinib 3 Oxaliplatin 3 Leucovorin 3 Injections 3 Fluorouracil 3 Docetaxel 3 Cyclophosphamide 3 tocilizumab 2 tislelizumab 2 temsirolimus 2 ridaforolimus 2 plocabulin 2 pembrolizumab 2 pazopanib 2 olaparib 2 linifanib 2 fludarabine 2 envafolimab 2 darinaparsin 2 brigimadlin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02078349 2020-09-10

Phase I Study of KPT330 in Asian Patients

National University Hospital, Singapore

Phase 1 Completed

Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡